Carl D. Francis

Carl D Francis is a seasoned executive with extensive experience in leadership roles across various industries, including healthcare, technology, and finance. Currently serving as Chairman at Keyron Medical Technology since December 2022, Carl focuses on innovative treatments for metabolic diseases. Previously, Carl has held positions such as CEO at both Eyoto and P2i, successfully driving advancements in optical technologies and establishing a leading global position in liquid repellent coatings, respectively. As Chairman and Board Member at Ariel Savannah Angel Partners, Carl has contributed to investing over $19 million in startup companies. Previous roles include pivotal positions at Senior plc, The Caudwell Group, and in turnaround consulting for major corporations. Carl holds credentials as a Certified Public Accountant and is a graduate of the Institute of Executive Growth.